The CBRE Healthcare Capital Markets Group acted as the exclusive advisor for the monetization of the Texas U.S. Oncology Center.
Sale Date: May 23, 2013
Sale Price: $9,500,000
Price PSF: $323
Building Size: 29,400 SF
Year Built: 2000
Occupancy: 100%
The CBRE U.S. Healthcare Capital Markets Group is pleased to announce the sale of the Texas U.S. Oncology Center located in Austin, Texas. The 29,400 square foot two-story facility was constructed in 2000 and is 100% leased to and guaranteed by U.S. Oncology. Chris Bodnar, Lee Asher and Todd Mills represented the seller.
The building is located in northwest Austin and is positioned to treat all forms of cancer, from the most prevalent forms such as breast cancer, prostate cancer, skin cancer and lung cancer to more than 200 forms of cancer identified by the medical community. Treatments at the center include radiation oncology, PET/CT, SRS (Stereotactic Radiosurgery), HDR (High Dose Rate Brachytherapy) and IMRT (Intensity Modulated Radiation Therapy).
As part of the disposition, CBRE oversaw the successful loan assumption held by a prominent life insurance company. The loan balance at the time of closing was approximately $3.75 million, maturing in December of 2015 with a fixed 5.80% interest rate and 20-year amortization schedule.
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
Comments are closed, but trackbacks and pingbacks are open.